Navigation Links
USDM Life Sciences Announces New Solution for Continuous GxP Compliance on Microsoft
Date:7/22/2020

USDM Life Sciences, a premier consulting firm driving digital transformation and innovation in technology and compliance, announces a new solution to manage regulated workloads on Microsoft Azure.

Regulated biotechnology, pharmaceutical, and medical device companies must ensure every layer of their technology stack complies with FDA and global regulations. USDM's new managed service for regulated workloads in the public cloud covers end-to-end technology and compliance solutions to addresses business applications, cloud services, and global infrastructure. With Unify Public Cloud, Microsoft customers will get access to unmatched compliance services, fast-start accelerators, and defensible validation deliverables based on twenty years of regulatory domain expertise and technology solution implementation.

"Now, more than ever, life science companies are prioritizing their business transformation through cloud technologies to not only maintain business continuity but accelerate their high-impact growth outcomes," said Kevin Brown, CEO of USDM Life Sciences. "By providing a total, continuous, GxP compliant solution for regulated workloads, USDM can help minimize regulatory risk and maximize innovation for our customers creating vital drugs, therapies, and medical devices."

USDM's cost-effective, prepackaged, Unify Public Cloud solution speeds up the deployment and adoption of Azure, minimizes compliance risk, and realizes business value faster by leveraging decades of life sciences expertise.

"At Microsoft, we're focused on continually developing new ways to empower our customers to increase productivity and improve business outcomes," said Patty Obermaier, Vice President, U.S. Health & Life Sciences at Microsoft Corp. "USDM, delivers accelerated GxP solutions that enable continuous cloud compliance to help reduce regulatory burdens."

Unify Public Cloud for Azure addresses and meets a growing, critical demand for life science companies to enable complete digital business processes and efficiently manage GxP compliance requirements.

Learn More

Please join us for a webinar discussing how you can move your regulated GxP workload to Microsoft Azure.

Thursday, July 30th, 2:00 PM - 3:00 PM EDT

Register Here

Availability

Unify Public Cloud for Azure is available for all Microsoft life sciences customers on the Azure Marketplace. To learn how you can migrate your regulated workload to Azure, contact USDM at usdm@usdm.com.

About USDM Life Sciences

USDM Life Sciences provides strategy and compliant technology solutions to regulated life sciences companies and makes it easy to accelerate transformation and innovation. USDM Life Sciences focuses exclusively on the regulated biotechnology, pharmaceutical, and medical device industries and is a compliance partner with the world's top technology software developers. For more information, visit http://www.usdm.com.

Read the full story at https://www.prweb.com/releases/usdm_life_sciences_announces_new_solution_for_continuous_gxp_compliance_on_microsoft/prweb17267952.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. DuPont Nutrition & Biosciences Unveils Brewing Liquefaction Enzyme Solution AMYLEX® 6T
2. DuPont Nutrition & Biosciences Launches Bonlacta™ Dairy Enzyme in North America for Lactose-Free Market
3. Flagship Biosciences and Corritori Consulting Announce Strategic Alliance - Companies Now Delivering Regulatory Services to the Pharmaceutical Industry
4. Box, ComplianceQuest and USDM Life Sciences Partner to Launch Unify Compliance Cloud
5. Flagship Biosciences Hires New Vice President of Clinical Diagnostics
6. OU Health Sciences Center Partners With Pure MHC on COVID-19 Vaccine Project
7. Jason Burke Joins CREO, Inc. as Partner to Head Analytics and Data Sciences Practice
8. INDIGO Biosciences Announces Record Revenue Numbers for 2019
9. New Investments Boost Colorado’s Life Sciences Community
10. GIOSTAR Announces Medical Breakthrough in Biotechnology and Lifesciences To Manufacture Abundant, Safe Red Blood Cells From Stem Cells
11. GIOSTAR Announces Medical Breakthrough in Biotechnology and Lifesciences To Manufacture Abundant, Safe Red Blood Cells From Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
(Date:6/28/2020)... , ... June 25, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that it has entered ... innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... software and software-driven clinical data services that accelerate drug development, is collaborating with ... an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the first ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands ... , Known as MediVet Biologics since its formation in 2016, the company is ... Animal Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... and SOMERSET, N.J (PRWEB) , ... July 29, ... ... genome editing company, and Catalent, the leading global provider of advanced delivery technologies, ... health products, today announced that they have entered into a strategic partnership whereby ...
(Date:7/18/2020)... ... ... After research model surgery and catheter implantation, the long journey of catheter maintenance and ... successful study, while protecting and accessing the catheter or device post-surgery is often undervalued ... Envigo in a live webinar on Wednesday, August 5, 2020 at ...
(Date:7/10/2020)... (PRWEB) , ... July 09, ... ... biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded ... broader license allows PathSensors to move into the point-of-care diagnostic market, focusing ...
Breaking Biology Technology: